Breakthrough in Obesity Treatment: Tirzepatide Shows Promise in Chinese Adults - SURMOUNT-CN Trial
China: In the relentless battle against obesity, a new contender has emerged: tirzepatide. The results of the SURMOUNT-CN randomized clinical trial have ignited excitement within the medical community, as they unveil the potential of this novel drug in …